[Mycobacterium kansasii infection after liver transplantation]

Area of Science:

• Immunology
• Infectious Diseases
• Transplantation Medicine

Background:

• Solid organ transplant recipients require immunosuppression, increasing susceptibility to infections.
• Nontuberculous mycobacteria (NTM) infections, though infrequent, pose significant morbidity risks in this population.
• Managing NTM infections is complicated by drug interactions and toxicity with immunosuppressants.

Observation:

• A liver transplant recipient developed acute cholangitis.
• Concurrently, the patient acquired an uncommon infection with Mycobacterium kansasii.
• This M. kansasii infection occurred in the late post-transplantation period.

Findings:

• The case illustrates a poor outcome in an immunosuppressed liver transplant recipient.
• Mycobacterium kansasii represents a challenging pathogen in immunocompromised individuals.
• Treatment limitations, including drug interactions and toxicity, are prominent.

Implications:

• This case underscores the importance of vigilance for uncommon infections in transplant recipients.
• Optimizing treatment strategies for NTM infections in immunosuppressed patients is crucial.
• Further research into managing NTM infections post-transplantation is warranted.